Medique Loradamed Tablet
NDC 47682-403
Product Information
Medique Loradamed (loratadine) is a ANDA-approved product labeled by Unifirst First Aid Corporation. This medication is an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies. It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 47682-403 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
G;10
Code Structure Chart
Product Details
What is NDC 47682-403?
What are the uses of this product?
What are Active Ingredients of this product?
- LORATADINE 10 mg/1 - A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LORATADINE (UNII: 7AJO3BO7QN)
- LORATADINE (UNII: 7AJO3BO7QN) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STARCH, CORN (UNII: O8232NY3SJ)
- WATER (UNII: 059QF0KO0R)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 311372 - loratadine 10 MG 24HR Oral Tablet
- RxCUI: 311372 - loratadine 10 MG Oral Tablet
- RxCUI: 311372 - loratadine 10 MG 24 HR Oral Tablet
* Please review the full disclaimer at the bottom of this page.